1)paclitaxel liposome紫杉醇脂质体
1.Clinical analysis of paclitaxel liposome combined with carboplatin in the treatment of advanced epithelial ovarian cancer;紫杉醇脂质体联合卡铂治疗晚期卵巢上皮癌的临床分析
2.Therapeutic effect of paclitaxel liposome combined with cisplatin for Ⅲ～Ⅳ degrees of cervical cancer;紫杉醇脂质体在中晚期宫颈癌治疗的效果分析
3.Immunosuppressive effect of paclitaxel liposome on B lymphocytes紫杉醇脂质体B细胞免疫抑制作用的实验研究
英文短句/例句
1.Pharmacokinetics Study on Docetaxel Liposome in Rats多烯紫杉醇脂质体大鼠体内药物动力学研究
2.Preparation of Targeted Paclitaxel Liposomes and Study of Their Drug Effect;靶向性紫杉醇脂质体的制备及药效的初步研究
3.Immunosuppressive effect of paclitaxel liposome on B lymphocytes紫杉醇脂质体B细胞免疫抑制作用的实验研究
4.Safety of Pretreatment Protocols of Paclitaxel Liposome紫杉醇脂质体预处理用药方案的安全性研究
5.Effects of Acupuncture on Paclitaxel Liposome Tropism of Tumor Organization in Vivo in Lung Cancer Rats针刺对肺癌大鼠体内紫杉醇脂质体趋向性的影响
6.Killing effect of liposome encapsulated paclitaxel on endometrial carcinoma Ishikawa cell line in vitro紫杉醇脂质体对子宫内膜癌Ishikawa细胞的体外杀伤作用
7.Study on the Targeted Permeability of Superparamagnetic PTX Liposome Across Blood-brain Barrier超顺磁性紫杉醇脂质体靶向通透血脑屏障的实验研究
8.Paclitaxel liposome and cisplatin and fluorouracil for first-line treatment of advanced gastric cancer紫杉醇脂质体联合顺铂、氟尿嘧啶一线治疗晚期胃癌的临床观察
9.Application of neoadjunvant chemotherapy with paclitaxel liposome for injection and carboplatin in locally advanced cervical cancer紫杉醇脂质体联合卡铂在局部晚期宫颈癌新辅助化疗中的应用
10.The efficacy and safety of paclitaxel liposomes in the treatment of 30 patients with non-small cell lung cancer紫杉醇脂质体治疗非小细胞肺癌30例近期疗效及安全性分析
11.Clinical observation of neoadjuvant chemotherapy in breast cancer with paclitaxel liposome and pirarubicin紫杉醇脂质体联合吡柔比星在乳腺癌新辅助化疗中的临床观察
12.The histopathological changes of non-small cell lung cancer treated with paclitaxel liposome injection as primarily chemotherapy紫杉醇脂质体注射液初始化疗后非小细胞肺癌组织病理学变化
13.Paclitaxel liposome as monotherapy in elderly Chinese patients with advanced non-small cell lung cancer紫杉醇脂质体单药治疗老年晚期非小细胞肺癌的临床观察
14.Study of Long-circulation Thermosensetive Liposomes Contain Docetaxel;多西紫杉醇长循环热敏脂质体的研究
15.Depression effects of paclitaxel magnetic nanoparticle liposome on the growth of cancer cells in vitro紫杉醇磁性纳米脂质体的体外细胞抑瘤效果
16.Study of the Preparation and Characters of Nanostructure Lipid Carriers Containing Paclitaxel;紫杉醇纳米脂质载体的制备与特性研究
17.Paclitaxel Magnetic Liposomes Preparation and Animal Empirical Study;紫杉醇磁性脂质体制备及动物实验研究
18.Preparation and Characterization of PEGylated Paclitaxel Liposomes长循环紫杉醇纳米脂质体的合成及其活性评估
相关短句/例句
paclitaxel solid lipid nanoparticles紫杉醇固体脂质纳米粒
1.OBJECTIVE To establish a HPLC method for the determination of entrapment efficiency of paclitaxel solid lipid nanoparticles(paclitaxel solid lipid nanoparticles,PTX-SLN).目的建立紫杉醇固体脂质纳米粒(Paclitaxel Solid Lipid Nanoparticles,PTX-SLN)包封率的测定方法。
3)Paclitaxel liposome injection紫杉醇脂质体注射液
4)paclitaxel-carrying liposome microbubbles(PLM)载紫杉醇脂质微泡(PLM)
5)paclitaxel nanoparticle紫杉醇脂质纳米粒子
1.Objective: To study and analysis the mechanism of action and inhibitory effect of a new type paclitaxel nanoparticle (TAX-NLC) on KB and SKOV3 cells for developing a new targeted pharmaceutical to human tumor.目的:研究探讨新型紫杉醇脂质纳米粒子(TAX-NLC)对KB、SKOV3细胞的抑制作用与作用机制,为研制新型肿瘤靶向治疗药物提供实验依据。
6)paclitaxel lipid nanoparticles紫杉醇脂质纳米粒
1.OBJECTIVE To prepare paclitaxel lipid nanoparticles for intravenous injection and investigate its release characteristics in vitro and its pharmacokinetics in rats.目的制备注射用紫杉醇脂质纳米粒,并考察其理化性质、体外释放及体内药动学性质。
延伸阅读
多相脂质体139 , 三氨酸多相脂质体,油酸多相脂质体注射液药物名称：油酸多相脂质体注射液英文名：Polyphase Liposome-139别名： 139;多相脂质体139 , 三氨酸多相脂质体,油酸多相脂质体注射液外文名：Polyphase Liposome-139适应症： 用于治疗各种消化管癌（如胃癌、结肠癌、肝癌、胰腺癌、食管癌等）、肺癌、淋巴肉瘤、乳腺癌等。 用量用法： 开始时１日量２０ｍｌ，如无不良反应，逐渐增大剂量，最多可至１日５０ｍｌ，加入氯化钠注射液中（２５０～５００ｍｌ）混匀，缓缓静滴，滴速控制在每分钟４０～６０滴，每日１次，１个疗程总量１２００～１５００ｍｌ。如单用本品，１个疗程结束后，休息１周，进行复查，然后继续第２疗程。如是手术病人，术后２周开始维持给药，１日５０ｍｌ，每周２次，用１个月。本品亦可与化疗或放疗合用，先用本品１疗程，休息１周后，，再按常规使用化疗或放疗，可减轻化疗药物的毒副作用，提高机体免疫功能。 注意事项： 1.用前将注射液振摇均匀后与等渗盐水混匀。 2.偶有面部发热，仅需减慢滴速即能恢复正常。 3.禁用于直接静脉推注，以免危险。 4.开始用药２～３日内白细胞可能略有下降，继续给药随即回升至正常水平。 规格： 针剂：１０ｍｌ。 类别：其他抗肿瘤药及辅助治疗药
